Autologous hemopoietic stem cell transplantation: A possible cure for rheumatoid arthritis?

Arthritis and Rheumatism

Volumn 40, Issue 6, 1997, Pages 1005-1011

  Wicks, Ian ^a   Cooley, Helen ^a   Szer, Jeff ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICULAR CARTILAGE; AUTOIMMUNITY; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CHEMOTHERAPY; CONTROLLED STUDY; DRUG MEGADOSE; HEMATOPOIETIC CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ARTHRITIS, RHEUMATOID; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0030953117     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400603     Document Type: Review

References (59)

1. Marmont AM: Immune ablation followed by allogeneic or autologous bone marrow transplantation: a new treatment for severe autoimmune diseases? Stem Cells (Dayt) 12:125-135, 1994
2. Brooks PM, Atkinson K, Hamilton JA: Stem cell transplantation in autoimmune disease. J Rheumatol 22:1809-1811, 1995
3. Tyndall A, Gratwohl A: Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases. Ann Rheum Dis 55:149-151, 1996
4. Snowden JA, Biggs JC, Brooks PM: Autologous blood stem cell transplantation for autoimmune disease. Lancet 348:1112-1113, 1996
5. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz PW, Haga M, Kleinheksel SM, Cathey MA: The mortality of rheumatoid arthritis. Arthritis Rheum 37:481-494, 1994
6. Scott DL, Symmons DP, Coulton BL, Popert AJ: Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet 1:1108-1111, 1987
7. Felson DT, Anderson JJ, Meenan RF: The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis: results of two metaanalyses. Arthritis Rheum 33:1449-1461, 1990
8. Pincus T: The case for early intervention in rheumatoid arthritis. J Autoimmun 5 (Suppl A):209-226, 1992
9. Ikehara S: The prospects for BMT-from mouse to human. In, Bone Marrow Transplantation: Basic and Clinical Studies, Edited by S Ikehara, F Takaku, RA Good. Tokyo, Springer-Verlag, 1996
10. Ikehara S, Kawamura M, Takao F, Inaba M, Yasumizu R, Than S, Hisha H, Sigiura K, Koide Y, Yoshida TO, Ida T, Imura H, Good RA: Organ-specific and systemic autoimmune diseases originate from defects in haematopoietic stem cells. Proc Natl Acad Sci U S A 87:8341-8344, 1990
11. Van Bekkum DW, Bohre EP, Houben PF, Knaan-Shanzer S: Regression of adjuvant-induced arthritis in rats following bone marrow transplantation. Proc Natl Acad Sci U S A 86:10090-10094, 1989
12. Knaan-Shanzer S, Houben P, Kinwel-Bohre EP, van Bekkum DW: Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone Marrow Transplant 8:333-338, 1991
13. Baldwin JL, Storb R, Thomas ED, Mannik M: Bone marrow transplantation in patients with gold-induced marrow aplasia. Arthritis Rheum 20:1043-1048, 1977
14. Jacobs P, Vincent MD, Martell RW: Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anaemia. Bone Marrow Transplant 1:237-239, 1986
15. Lowenthal RM, Cohen ML, Atkinson K, Biggs JC: Apparent cure of rheumatoid arthritis by bone marrow transplantation. J Rheumatol 20:137-140, 1993
16. Liu-Yin JA, Jowitt SN: Resolution of immune-mediated diseases following allogeneic bone marrow transplantation. Bone Marrow Transplant 9:31-33, 1992
17. McKendry RJR, Huebsch L, Leclair B: Progression of rheumatoid arthritis following bone marrow transplantation; a case report with a 13-year followup. Arthritis Rheum 39:1246-1253, 1996
18. MacGregor A, Ollier W, Thomson W, Jawaheer D, Silman A: HLA-DRB1*0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset and disease severity. J Rheumatol 22:1032-1036, 1995
19. Armitage JO: Bone marrow transplantation. N Engl J Med 330:827-838, 1994
20. Hawkins TE, Juttner CA: Blood cell transplantation. Curr Opin Oncol 7:122-129, 1995
21. Sheridan WP, Morstyn G, Wolf M, Dodds A, Lusk J, Maher D, Layton JE, Green MD, Souza L, Fox RM: Granulocyte colony stimulating factor and neutrophil recovery after high dose chemotherapy and autologous bone marrow transplantation. Lancet 2:891-895, 1989
22. Sheridan WP, Begley CG, To LB, Grigg A, Szer J, Maher D, Green MD, Rowlings PA, McGrath KM, Cebon J, Dyson P, Watson D, Bayly J, de Luca E, Tomita D, Hoffman E, Morstyn G, Juttner C, Fox RM: Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-close chemotherapy for lymphoid malignancies. Bone Marrow Transplant 14:105-111, 1994
23. Kotasek D, Sage RE, Dale BM, Norman JE, Bolton A: Dose intensive therapy with autologous blood stem cell transplantation in breast cancer. Aust N Z J Med 24:288-295, 1994
24. Atkinson K, Dodds A, Milliken S, Concannon A, Fay K, Harris M, Fleeknoe-Brown S, Lind D, McKinley R, Rutovitz J, Rosenfeld D, Harvey M, Downs K, Flattery D, Song J, Green A, Quigley V, Hawkins T: Autologous blood stem cell transplantation for haematological malignancy: treatment related mortality of 2%. Aust N Z J Med 25:483-489, 1995
25. Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF, Casassus P, Maisonneuve H, Facon T, Ifrah N, Payen C, Bataille R: A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med 335:91-97, 1996
26. Basser RL, To LB, Begley CG, Juttner CA, Maher DW, Szer J, Cebon J, Collins JP, Russell I, Olver I, Gill PG, Fox RM, Sheridan WP, Green MD: Adjuvant treatment of high-risk breast cancer using multicycle high-dose chemotherapy and filgrastim-mobilized peripheral blood progenitor cells. Clin Cancer Res 1:715-721, 1995
27. McGlave PB, de Fabritiis P, Deisseroth A, Goldman J, Barnett M, Reiffers J, Simonsson B, Carella A, Aeppli D: Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups. Lancet 343:1486-1488, 1994
28. Philip T, Guglielmi C. Hagenbeek A, Somers R, van der Lelic H, Bron D, Sonneveld P, Gisselbrecht C, Cahn JY, Harousseau JL, Coiffier B, Biron P, Mandelli F, Chauvin F: Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333:1540-1545, 1995
29. De Vita S, Neri R, Bombardieri S: Cyclophosphamide pulses in the treatment of rheumatic diseases: an update. Clin Exp Rheumatol 9:179-193, 1991
30. Winchester R: The molecular basis of susceptibilty to rheumatoid arthritis. Adv Immunol 56:389-466, 1994
31. Lanchbury JS, Hall MA: T cell receptor usage in rheumatoid arthritis. Br Med Bull 51:346-358, 1995
32. Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H, Woody JN: Randomised double blind comparison of chimaeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105-1110, 1994
33. Koopman WJ, Gay S: Do nonimmunologically mediated pathways play a role in the pathogenesis of rheumatoid arthritis? Rheum Dis Clin North Am 19:107-122, 1993
34. Zvaifler NJ, Firestein GS: Pannus and pannocytes: alternative models of joint destruction in rheumatoid arthritis. Arthritis Rheum 37:783-789, 1994
35. Berg LJ, Frank GD, Davis MM: The effects of MHC gene dosage and allelic variation on T cell receptor selection. Cell 60:1043-1053, 1990
36. Walser-Kuntz DR, Weyand CM, Weaver AJ, O'Fallon WM, Goronzy JJ: Mechanisms underlying formation of the T cell receptor repertoire in rheumatoid arthritis. Immunity 2:597-605, 1995
37. Carson DA, Chen PP, Kipps TJ: New roles for rheumatoid factor. J Clin Invest 87:379-383, 1991
38. Edwards JC, Willoughby DA: Demonstration of bone marrow derived cells in synovial lining by means of giant intracellular granules as genetic markers. Ann Rheum Dis 41:177-182, 1982
39. Qu Z, Garcia CH, O'Rourkc LM, Planck SR, Kohli M, Rosenbaum JT: Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia: results of proliferating cell nuclear antigen/cyclin, c-myc, and nuclear organizer region staining. Arthritis Rheum 37:212-220, 1994
40. Hamilton JA: Rheumatoid arthritis: opposing actions of haemopoietic growth factors and slow-acting anti-rheumatic drugs. Lancet 342:536-539, 1993
41. Verma UN, Mazumder A: Immune reconstitution following bone marrow transplantation. Cancer Immunol Immunother 37:351-360, 1993
42. Mackall CL, Fleisher TA, Brown MR, Magrath IT, Shad AT, Horowitz ME, Wexler LH, Adde MA, McClure LL, Gress RE: Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 44:2221-2228, 1994
43. Mackall CL, Bare CV, Granger LA, Sharrow SO, Titus JA, Gress RE: Thymic-independent T cell regeneration occurs via antigen driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol 156:4609-4616, 1996
44. Rocha B, Gromdien A, Freita AA: Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance. J Exp Mod 181:993-1003, 1995
45. Ollier WE, MacGregor A: Genetic epidemiology of rheumatoid disease. Br Med Bull 51:267-285, 1995
46. Jarvinen P, Aho K: Twin studies in rheumatic diseases. Semin Arthritis Rheum 24:19-28, 1994
47. Miller JF, Morahan G: Peripheral T cell tolerance. Annu Rev Immunol 10:51-69, 1992
48. Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Sewell KL, Hafler DA, Weiner HL: Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261:1727-1730, 1993
49. Janossy G: "Purging" of bone marrow and imunosuppression. Br Med Bull 40:247-253, 1984
50. Schiller G, Vescio R, Freytes C, Spitzer G, Sahebi F, Lee M, Wu CH, Cao J, Lee JC, Hong CH, Liu M, Hall J, Berenson R, Berenson J: Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 86:390-397, 1995
51. Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE, Gluckman E: Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 346:214-219, 1995
52. Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, Hoover R, Fraumeni JF: Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 85:307-311, 1993
53. Matteson EL, Hickey AR, Maguire L, Tilson HH, Urowitz MB: Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in a DMARD registry. J Rheumatol 18:809-814, 1991
54. Wandt H, Seifert M. Falge C, Gallmeier WM: Long-term correction of neutropenia in Felty's syndrome with granulocyte colonystimulating factor. Ann Hematol 66:265-266, 1993
55. Lubeck DP, Spitz PW, Fries JF, Wolfe F, Mitchell DM, Roth SH: A multicenter study of annual health service utilization and costs in rheumatoid arthritis. Arthritis Rheum 29:488-493, 1986
56. Slevin ML, Stubbs L, Plant HJ, Wilson P, Gregory WM, Armes PJ, Downer SM: Attitudes to chemotherapy: comparing views of patients with those of doctors, nurses, and general public. BMJ 300:1458-1460, 1990
57. Vose JM, Kennedy BC, Bierman PJ, Kessinger A, Armitage JO: Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies. Cancer 69:784-789, 1992
58. O'Brien BJ, Elswood J, Calin A: Willingness to accept risk in the treatment of rheumatic disease. J Epidemiol Community Health 44:249-252, 1990
59. Thompson MS: Willingness to pay and accept risks to cure chronic disease. Am J Public Health 76:392-396, 1986